AMPK activator resveratrol has been reported to inhibit growth of imitinib-resistant chronic myeloid leukemia (CML) cells by mTOR inhibition [30]. The gene discussed is MTOR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.